about
Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemiaActivation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liverRole of ADP ribosylation factor 1 in the assembly and secretion of ApoB-100-containing lipoproteinsEpigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDLMolecular cloning of human apolipoprotein B cDNA.RETRACTED: The SNARE protein SNAP23 and the SNARE-interacting protein Munc18c in human skeletal muscle are implicated in insulin resistance/type 2 diabetes.Myocardial release of FKBP12 and increased production of FKBP12.6 in ischemia and reperfusion experimental models.Assembly of very low density lipoprotein: a two-step process of apolipoprotein B core lipidation.The assembly and secretion of apolipoprotein B-containing lipoproteins.The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction.Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease.Isolation and partial characterization of the lipoprotein families A and A-I from high-density lipoproteins of human serum.The molecular mechanism for the assembly and secretion of ApoB-100-containing lipoproteins.Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.Triglyceride containing lipid droplets and lipid droplet-associated proteins.Lipid droplets as dynamic organelles connecting storage and efflux of lipids.ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan.The assembly of lipid droplets and its relation to cellular insulin sensitivity.The formation of lipid droplets: possible role in the development of insulin resistance/type 2 diabetes.Apolipoprotein B: structure, biosynthesis and role in the lipoprotein assembly process.Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes.Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.Atherosclerosis basic mechanisms.Studies on human serum high-density lipoproteins (HDL). IV. Isolation of lipoprotein families after incubation of HDL.Studies on human serum high-density lipoproteins. V. Isolation and characterization of a cholesterol ester-rich lipoprotein after in vitro incubation.Studies on human serum high-density lipoproteins. VI. Studies on a cholesterol ester-releasing reaction in vitro.SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity.Isolation and partial characterization of a glycine- and serine-rich polypeptide from human serum high-density lipoproteins (HDL).Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low-density lipoproteins.Relation of the size and intracellular sorting of apoB to the formation of VLDL 1 and VLDL 2.Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48.The assembly and secretion of apoB-100-containing lipoproteins.Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms.Intracellular assembly and degradation of apolipoprotein B-100-containing lipoproteins in digitonin-permeabilized HEP G2 cells.Brefeldin A reversibly inhibits the assembly of apoB containing lipoproteins in McA-RH7777 cells.Studies on the assembly of apolipoprotein B-100- and B-48-containing very low density lipoproteins in McA-RH7777 cells.Evidence for a structural relationship between apoB75kDa and human plasma apolipoprotein B 100, from translation of human liver mRNA in vitro and immunochemical studies with monoclonal and polyclonal antibodies.The assembly and secretion of ApoB 100-containing lipoproteins in Hep G2 cells. ApoB 100 is cotranslationally integrated into lipoproteins.Alphalipoprotein cholesterol and arterial cholesterol in human uterine arteries.The assembly and secretion of apoB 100 containing lipoproteins in Hep G2 cells. Evidence for different sites for protein synthesis and lipoprotein assembly.
P50
Q28256835-E83DA79C-0998-4295-B0B7-2A8FD01B61ABQ28570588-E9DB9871-C635-4EBC-8894-635F7A03157AQ28574311-2E0AE8A9-128E-4747-8DAE-D2E0C67FC284Q28582707-091282A0-2BB7-4285-A80C-A0D0242B008FQ30406574-D9B20522-DC4E-456D-B2CD-306A27D25F40Q30495722-0CF41063-C2A5-4F84-A6CF-38A39FB614A7Q33514155-4373F18C-08A0-4122-9CB3-D1C9398A256DQ33537986-BE8A84EB-EA02-4399-9EDA-BBF8C274E03FQ33730869-1CCAEF73-E84A-45FF-9FE3-DC9D6BAC3EF4Q35572373-7D6211E3-D169-414B-847B-079D7BBD1C8FQ36536256-64344A94-F5C1-4D5B-9504-DAF98239FB87Q36630290-D61C176F-AB49-4FAD-8ACB-FBB3BE446D0EQ37073388-BD827BE6-44EC-4FD8-A61D-A088B038E739Q37195515-73CD4FB4-89E2-46A2-8082-0E42403678A8Q37260156-AA94CD1F-0441-4557-9767-4371AC5AA79BQ37262586-9D8974F3-AC62-4462-B82F-5652FA7CC0EFQ37317424-4691CDEE-038F-422B-8593-CB18EE07F867Q37597348-875E8E16-063A-41AF-BE16-73A583ADD1DDQ37877380-CCDDF907-8327-43A2-AC4C-759007598285Q38348455-417FB3D6-E1C2-4C35-85D4-86F6A3AD63EDQ38354850-A6F6154B-380C-4BBC-9F23-82E6CA03A985Q39648172-77EFEAF0-52EA-40B0-9F81-EAEA89F3813BQ39756597-73F937C8-CCB5-401E-83A8-7D8D9E841199Q39959517-C1A31781-FCD4-4305-BCAC-C57CCE55CF81Q39981772-B17C1FFA-5811-4092-AC9F-2AD48C2CC130Q40023318-0C0FF4C6-863B-465F-B0E3-C597EA13AD23Q40070807-0E9F6ECE-B082-4A02-83BD-36EA00F4EC5EQ40126258-D9CD8E8A-B9D3-4ACE-A954-2C1744152910Q40289718-A5A5D544-40DB-4FC8-8C04-BCF24E625252Q40497114-42345165-4FBB-463F-BE91-D84FA74E265EQ40741210-9F27CFE7-B81D-484F-8D17-288EDE98FE4AQ40839808-96891F28-7EC7-4C92-B130-C135A5C2FB90Q40954752-31CDE037-F343-47C8-B476-FD4145C20016Q41126991-98EF44AE-2DD2-4730-96F4-03E0016D58FBQ41267545-152C4F70-08FD-48B0-B26E-D16828A2BBE5Q41435923-E384481E-6F77-4BA7-B656-2C2E663C8AE0Q41572707-58837147-C4F8-410F-802C-9C26C7B959EBQ41624497-C10ED9F8-9CFA-4F97-8127-3E54481FC247Q41632398-2637B444-9B37-4346-8017-665D17B012FEQ41730480-304E3BE6-1AA1-498F-8FB6-4ED019D88442
P50
description
Swedish researcher
@en
Zweeds onderzoeker (1947-2011)
@nl
svensk forsker
@nb
name
Sven-Olof Olofsson
@da
Sven-Olof Olofsson
@de
Sven-Olof Olofsson
@en
Sven-Olof Olofsson
@es
Sven-Olof Olofsson
@fr
Sven-Olof Olofsson
@nb
Sven-Olof Olofsson
@nl
Sven-Olof Olofsson
@nn
Sven-Olof Olofsson
@sl
Sven-Olof Olofsson
@sv
type
label
Sven-Olof Olofsson
@da
Sven-Olof Olofsson
@de
Sven-Olof Olofsson
@en
Sven-Olof Olofsson
@es
Sven-Olof Olofsson
@fr
Sven-Olof Olofsson
@nb
Sven-Olof Olofsson
@nl
Sven-Olof Olofsson
@nn
Sven-Olof Olofsson
@sl
Sven-Olof Olofsson
@sv
prefLabel
Sven-Olof Olofsson
@da
Sven-Olof Olofsson
@de
Sven-Olof Olofsson
@en
Sven-Olof Olofsson
@es
Sven-Olof Olofsson
@fr
Sven-Olof Olofsson
@nb
Sven-Olof Olofsson
@nl
Sven-Olof Olofsson
@nn
Sven-Olof Olofsson
@sl
Sven-Olof Olofsson
@sv
P106
P21
P27
P31
P569
1947-01-01T00:00:00Z
P570
2011-01-01T00:00:00Z